We assessed the prevalence of auto-Abs in IP patients by testing plasma samples from all the patients of the cohort for neutralizing activity in a luciferase IFN-stimulated response element (ISRE) reporter assay. The gene discussed is IFNA1; the disease is incontinentia pigmenti.